Use of high sensitivity C-reactive protein and DG9-glycan index for differential diagnosis of maturity-onset diabetes of the young due to HNF1A mutations in young adults

Ítems similars

• Evaluation of high sensitivity C-reactive protein as a screening tool for detecting young South Asians with maturity-onset diabetes of the young due to HNF1A mutations
  per: Mughal, SA, et al.
  Publicat: (2013)
• Maturity onset diabetes of the young due to HNF1A variants in Croatia
  per: Pavić, T, et al.
  Publicat: (2018)
• Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
  per: Juszczak, A, et al.
  Publicat: (2018)
• Identification and assessment of glycan profiles as a biomarker for maturity onset diabetes of the young (MODY) due to hepatocyte nuclear factor 1 alpha (HNF1A) mutations
  per: Gloyn, A, et al.
  Publicat: (2011)
• Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
  per: Owen, K, et al.
  Publicat: (2010)